Evidence map›Paper›PMID 28670373›Full record

ArticleAmerican journal of translational research2017

ZEB2 promotes tumor metastasis and correlates with poor prognosis of human colorectal cancer.

Ming-Zhe Li, Jing-Jing Wang, Shi-Bin Yang, Wen-Feng Li, Long-Bin Xiao, Yu-Long He, Xin-Ming Song

Open access · greenAbstract read
In one paragraph

Article in American journal of translational research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
5.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 56 citations in OpenAlex.

  1. HHIP's dynamic role in epithelial wound healing reveals a potential mechanism of COPD susceptibility.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. The Roles of Zinc Finger Proteins in Colorectal Cancer.International journal of molecular sciences · 2023
    Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Biomedicines · 2022
    Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Ming-Zhe LiDepartment of Gastrointestinal and Pancreatic Surgery, The Eastern Hospital of The First Affiliated Hospital, Sun Yat-sen UniversityNo. 183 Huangpu East Road, Huangpu District, Guangzhou, China.
Jing-Jing WangDepartment of Laboratory, Hexian Memorial Hospital of Panyu DistrictNo. 2 Qinghe East Road, Panyu District, Guangzhou, China.
Shi-Bin YangDepartment of Gastrointestinal and Pancreatic Surgery, The Eastern Hospital of The First Affiliated Hospital, Sun Yat-sen UniversityNo. 183 Huangpu East Road, Huangpu District, Guangzhou, China.
Wen-Feng LiDepartment of Gastrointestinal and Pancreatic Surgery, The Eastern Hospital of The First Affiliated Hospital, Sun Yat-sen UniversityNo. 183 Huangpu East Road, Huangpu District, Guangzhou, China.
Long-Bin XiaoDepartment of Gastrointestinal and Pancreatic Surgery, The Eastern Hospital of The First Affiliated Hospital, Sun Yat-sen UniversityNo. 183 Huangpu East Road, Huangpu District, Guangzhou, China.
Yu-Long HeDepartment of Gastrointestinal and Pancreatic Surgery, The First Affiliated Hospital, Sun Yat-sen UniversityNo. 58 Zhongshan Er Road, Guangzhou, China.
Xin-Ming SongDepartment of Gastrointestinal and Pancreatic Surgery, The First Affiliated Hospital, Sun Yat-sen UniversityNo. 58 Zhongshan Er Road, Guangzhou, China.
Sun Yat-sen University · CNPanyu Hospital of Chinese Medicine · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Colorectal cancer remains the most common cause of cancer-related deaths worldwide and it continues to lack an effective treatment. Here, we found that zinc finger E-box binding homeobox 2 (ZEB2) was overexpressed in several colorectal cancer cell lines and colorectal cancer specimens relative to adjacent non-cancerous tissues. Although ZEB2 has been reported to be associated with several tumors, its involvement in colorectal cancer progression remains unclear. In this study, we investigated the biological functions and molecular mechanisms of ZEB2 underlying colorectal carcinoma metastasis and angiogenesis. HCT116 colorectal cancer cells were treated with ZEB2 shRNA or recombinant ZEB2, and the expression of ZEB2 was assessed using reverse transcriptase polymerase chain reaction (RT-PCR) and immunoblotting, respectively. Ectopic expression of ZEB2 induced proliferation and epithelial-mesenchymal transition (EMT), and increased the metastatic capacity of HCT116 cells in vitro and in vivo. Furthermore, endothelial cell tube formation and angiogenesis in chick embryo chorioallantoic membrane (CAM) were accelerated by conditioned medium from ZEB2-overexpressing HCT116 cells. Further, overexpression of ZEB2 accelerated tumor growth and angiogenesis in xenotransplantation models. However, silencing endogenous ZEB2 caused an opposite outcome. Our results provide new evidence that ZEB2 promotes the progression of colon cancer, and thereby might represent a novel therapeutic target for colorectal carcinoma.

Indexed as

angiogenesiscolorectal cancermetastasisZEB2

Identifiers

PMID28670373
PMCPMC5489885
OpenAlexW2727408825

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.